MENINGIOMA, MALIGNANT

Clinical trials for MENINGIOMA, MALIGNANT explained in plain language.

Never miss a new study

Get alerted when new MENINGIOMA, MALIGNANT trials appear

Sign up with your email to follow new studies for MENINGIOMA, MALIGNANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for brain tumor patients: drug shows promise in slowing recurrent meningioma

Disease control Recruiting now

This study tests a drug called regorafenib in people whose meningioma (a type of brain tumor) has come back after previous treatment. The drug works by blocking blood vessel growth and other signals that help tumors grow. About 104 participants will receive the drug to see if it …

Matched conditions: MENINGIOMA, MALIGNANT

Phase: PHASE2 • Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Disease control

Last updated May 14, 2026 12:03 UTC

MENINGIOMA, MALIGNANT

Get alerted when new MENINGIOMA, MALIGNANT trials appear

New hope for brain tumor patients: drug shows promise in slowing recurrent meningioma